Compounds > 2-(n,n-dipropyl)amino-6,7-dihydroxytetralin
Page last updated: 2024-09-03

2-(n,n-dipropyl)amino-6,7-dihydroxytetralin and 4-butyrolactone

2-(n,n-dipropyl)amino-6,7-dihydroxytetralin has been researched along with 4-butyrolactone in 1 studies

Compound Research Comparison

Studies
(2-(n,n-dipropyl)amino-6,7-dihydroxytetralin)		Trials
(2-(n,n-dipropyl)amino-6,7-dihydroxytetralin)		Recent Studies (post-2010)
(2-(n,n-dipropyl)amino-6,7-dihydroxytetralin)		Studies
(4-butyrolactone)		Trials
(4-butyrolactone)		Recent Studies (post-2010) (4-butyrolactone)
11004,456781,823

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feenstra, MG; Horn, AS; Westerink, BH; Wirix, E1

Other Studies

1 other study(ies) available for 2-(n,n-dipropyl)amino-6,7-dihydroxytetralin and 4-butyrolactone

ArticleYear
Certain dopamine agonists increase dopamine synthesis in the striatum of rat brain.
    European journal of pharmacology, 1984, Jun-01, Volume: 101, Issue:3-4

    Topics: 4-Butyrolactone; Animals; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Haloperidol; Kinetics; Olfactory Bulb; Rats; Rats, Inbred Strains; Tetrahydronaphthalenes

1984